NEXGEL, Inc. (NXGLW)
NASDAQ: NXGLW · Real-Time Price · USD · Warrants
0.0386
+0.0144 (59.50%)
Jun 26, 2026, 4:00 PM EDT - Market closed

Company Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions.

It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment.

In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names.

The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.

NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

NEXGEL, Inc.
NEXGEL logo
Country United States
Founded 2009
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 19
CEO Adam Levy

Contact Details

Address:
2150 Cabot Boulevard West, Suite B
Langhorne, Pennsylvania 19047
United States
Phone 215 702 8550
Website nexgel.com

Stock Details

Ticker Symbol NXGLW
Exchange NASDAQ
Stock Type Warrants
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001468929
CUSIP Number 65344E115
ISIN Number US65344E1156

Key Executives

Name Position
Adam R. Levy Chief Executive Officer, President and Director
Ian Blackman CPA Chief Financial Officer
Gregory J. Robb Vice President of Operations